Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 430
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00577694 | Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT01571024 | BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer | ||
| NCT03569761 | A Culturally-adapted Colorectal Cancer Screening Decision Aid Designed for American Indians | ||
| NCT01412229 | Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | ||
| NCT04342260 | Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes | ||
| NCT01789983 | Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy | ||
| NCT07630168 | Effects of Infusion Timing on Treatment Response in Solid Tumors | ||
| NCT07226271 | Consumer Perceptions of Alcoholic Beverages | ||
| NCT04342871 | An Evaluation of the Families Addressing Cancer Together (FACT) Intervention | ||
| NCT06090864 | ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells | ||
| NCT07313306 | Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise | ||
| NCT01849614 | Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart | ||
| NCT06674889 | Rehabilitation Outcomes Study | ||
| NCT00998101 | Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy | ||
| NCT01492881 | Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma | ||
| NCT00489216 | Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids | ||
| NCT07065552 | Tirzepatide in Obesity-Driven Endometrial Cancer | ||
| NCT00266110 | Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT03820024 | MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback | ||
| NCT01530997 | De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca | ||
| NCT01262820 | Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab | ||
| NCT01298570 | Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer | ||
| NCT01137825 | Registry of Older Patients With Cancer | ||
| NCT01759355 | Hybrid PET/MR in the Therapy of Cervical Cancer | ||
| NCT03978624 | Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer | ||
| NCT07639242 | Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC | ||
| NCT01612351 | Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery | ||
| NCT05096923 | UNC Childhood, Adolescent, and Young Adult Cancer Cohort | ||
| NCT06276946 | Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia | ||
| NCT03862105 | Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer | ||
| NCT07520188 | C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States | ||
| NCT07829146 | Feasibility Pilot of AYA-PARTNER | ||
| NCT03156244 | Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients | ||
| NCT03717844 | Registry for Adults With Plasma Cell Disorders (PCD's) | ||
| NCT05743426 | Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies | ||
| NCT07808671 | A Decision Support Tool for Pancreatic Cancer Screening -Aim 2 | ||
| NCT05911308 | Abequolixron (RGX-104) and Durvalumab in Lung Cancer | ||
| NCT06618300 | Streamlined Resin Y90 Radiation Segmentectomy for Small HCC | ||
| NCT04083495 | CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma | ||
| NCT00520000 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors | ||
| NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | ||
| NCT01528878 | Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases | ||
| NCT05574478 | Metastatic Breast Cancer-Specific Prognostic Tool | ||
| NCT03488862 | Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients | ||
| NCT05620342 | Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer | ||
| NCT02030353 | The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer Survivors | ||
| NCT02276560 | Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC | ||
| NCT01234467 | Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma | ||
| NCT00467727 | Visibility of Lesion Characteristics With Phase Contrast Mammography | ||
| NCT03595878 | Trial of Parotid Sparing Whole Brain Radiation |
